Download Free Sample Report

Alteplase Market, Global Outlook and Forecast 2022-2028

Alteplase Market, Global Outlook and Forecast 2022-2028

  • Published on : 09 August 2022
  • Pages :76
  • Report Code:SMR-7260630

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Alteplase (trade names Activase, Actilyse) is a thrombolytic drug, used to treat acute myocardial infarctions (heart attacks) and other severe conditions caused by blood clotting by breaking up the blood clots that cause them.
This report contains market size and forecasts of Alteplase in global, including the following market information:
Global Alteplase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alteplase Market Sales, 2017-2022, 2023-2028, (MIU)
Global top five Alteplase companies in 2021 (%)
The global Alteplase market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alteplase include Boehringer-Ingelheim, Genentech and Hoffmann La Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Alteplase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alteplase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MIU)
Global Alteplase Market Segment Percentages, by Type, 2021 (%)
Powder
Solution
Global Alteplase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MIU)
Global Alteplase Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Alteplase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MIU)
Global Alteplase Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alteplase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alteplase revenues share in global market, 2021 (%)
Key companies Alteplase sales in global market, 2017-2022 (Estimated), (MIU)
Key companies Alteplase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer-Ingelheim
Genentech
Hoffmann La Roche